• Enhancement of Transamniotic Stem Cell Therapy for Spina Bifida by Genetic Engineering of Donor Mesenchymal Stem Cells with an Fgf2 Transgene

    1 day ago - By Journal of Pediatric Surgery

    : We examined whether engineered overexpression of fibroblast growth factor-2 in donor mesenchymal stem cells could enhance spina bifida coverage induced by transamniotic stem cell therapy .
    Read more ...